in 
Publications 
1. Cancer Treatment , eds. Haskell C.M., W.B. Saunders Company (Philadelphia), p. 295, 
1990. 
2. Berek, J.S., Hacker, N.F. Practical Gynecologic Oncology. Baltimore, Williams & 
Wilkins, p. 342, 1989. 
3. Thigpen, J.T. Ovarian Cancer. Boston, Martinux Nijhoft, p. 115, 3985. 
Berek, J.S. Obstet. Gynecol. 67:685, 1988. 
Mitchell, M.S., Kan-Mitchell, J., Kempf, R.A., Harel, W., Shau, H., Lind, S. Active specific 
immunotherapy for melanoma: Phase I trial of allogeneic lysates and a novel adjuvant. 
Cancer Res. 48:5883-5893, 1988. 
6. Morton, D., Nizze, A., Foshag, L., Hoon, D., Famatiga, E., Gupta, R., Irie, R. Proc. Am. 
Asso. Con. Res. 31:281, 1990. 
7. Wallack, M.K., Bash, J.A., Leftheriotis, E., Seigler, H., Bland, K., Wanebo, H., Balch, C., 
Bartolucci, A. A. Positive relationship of clinical and serologic responses to vaccinia 
melanoma oncolysate. Arch. Surg. 122:1460-1463, 1987. 
8. Bystryn, J.-C., Oratz, R., Harris, M.N., Roses, D.F., Golomb, F.M., Speyer, J.L. 
Immunogenicity of a polyvalent melanoma antigen vaccine in humans. Cancer 61 :1065- 
1070, 1988. 
9. McCune, C. S., Schapira, D.V., Henshaw, E.C. Specific immunotherapy of advanced 
renal carcinoma: evidence for the polyclonality of metastases. Cancer, 47:1984-1987, 
1981. 
10. Sahasrabudhe, D.M., deKernion, J.B., Pontes, J.E., Ryan, D.M., O’Donnell, R.W., Marquis, 
D.M., Mudholkar, G.S., McCune, C.S. Specific immunotherapy with suppressor function 
inhibition for metastatic renal cell carcinoma. J. Biol. Resp. Mod., 5:581-594, 1986. 
11. McCune, C., O'Donnell, R., Marquis, D., and Sahasrabudhe, D. Renal cell carcinoma 
treated by vaccines for active specific immunotherapy: Correlation of survival with skin 
testing by autologous tumor cells. In Press. 
12. Berd, D., Maguire, H.C., Mastrangelo, M.J. Induction of cell-mediated immunity to 
autologous melanoma cells and regression of metastases after treatment with a 
melanoma cell vaccine preceded by cyclophosphamide. Cancer Res. 46:2572-2577, 
1986. 
13. Hoover, H.C., Surdyke, M., Dangel, R.B., Peters, L.C., Hanna, M.G. Delayed cutaneous 
hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with 
an autologous tumor cell: Bacillus Calmette-Guerin vaccine. Cancer Res. 44:1671-1676, 
1984. 
14. Hoover, H.C., Surdyke, M.G., Dangel, R.B., Peters, L.C., Hanna, M.G. Prospectively 
randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer. 
Cancer 55:1236-1243, 1985. 
15. Ollson, L., Ebbessen P. Natural polyclonality of spontaneous AKR leukemia an its 
consequences for so-called specific immunotherapy. J. Natl. Cancer Inst. 62:623-627, 
1979. 
16. Economou, G., Takeichi, N., Boone, C.W. Common tumor rejection antigens in 
methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor 
protection and radioisotopic footpad assay. Cancer Res. 37:37-41, 1977. 
17. Rosenberg, S.A., Abersold, P., Cornetta, K., Kasid, A., Morgan, R., Moen, R., et al. Gene 
transfer into humans - Immunotherapy of patients with advanced carcinoma. 
[600] 
Recombinant DNA Research, Volume 15 
